Herantis Granted US Patent for Therapeutic Use of MANF for Epilepsy, Other Neurological Diseases
News Herantis Pharma was granted a patent by the U.S. Patent and Trademark Office (USPTO) for the use of MANF (mesencephalic astrocyte-derived neurotrophic factor) in the treatment of neurological diseases like ... Read more